By covalent binding of recombinant interleukin-2 (rIL-2) to Sepharose,
it was possible to immunopurify specific human anti-IL-2 antibodies f
rom a pool of immunoglobulins obtained from healthy subjects. Since lo
w quantities of the ligand released by the matrix could interfere with
the evaluation of the biological activity of anti-IL-2 antibodies, th
e antibody preparation was subjected to pepsin digestion which is know
n to destroy the IL-2 molecule. Purified human anti-IL-2 antibodies we
re found to be mostly IgG1 and able to neutralize IL-2 induced periphe
ral blood lymphocytes (PBL) proliferation in vitro. The availability o
f purified anti-IL-2 antibodies, obtained from healthy individuals, ab
le to modulate IL-2 activity, could be important in several therapeuti
c approaches.